These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1326273)

  • 21. Pathogenesis of infectious bursal disease in chickens infected with virus at various ages.
    Fadly AM; Nazerian K
    Avian Dis; 1983; 27(3):714-23. PubMed ID: 6314977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative pathogenesis of serotype 1 and variant serotype 1 isolates of infectious bursal disease virus and their effect on humoral and cellular immune competence of specific-pathogen-free chickens.
    Sharma JM; Dohms JE; Metz AL
    Avian Dis; 1989; 33(1):112-24. PubMed ID: 2539070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenicity of cell culture-derived and bursa-derived infectious bursal disease viruses in specific-pathogen-free chickens.
    Abdel-Alim GA; Saif YM
    Avian Dis; 2001; 45(4):844-52. PubMed ID: 11785889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.
    Van Reeth K; Braeckmans D; Cox E; Van Borm S; van den Berg T; Goddeeris B; De Vleeschauwer A
    Vaccine; 2009 Oct; 27(45):6330-9. PubMed ID: 19840669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virus-neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens.
    Fahey KJ; McWaters P; Brown MA; Erny K; Murphy VJ; Hewish DR
    Avian Dis; 1991; 35(2):365-73. PubMed ID: 1713030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-idiotypic antibody specific for an infectious bursal disease virus-neutralizing monoclonal antibody does not interfere with the virus infection.
    Yamaguchi T; Igusa A; Setiyono A; Fukushi H; Hirai K
    Arch Virol; 2002 Oct; 147(10):2017-23. PubMed ID: 12376762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Single and combined infections of specific-pathogen-free chickens with infectious bursal disease virus and an intestinal isolate of reovirus.
    Moradian A; Thorsen J; Julian RJ
    Avian Dis; 1990; 34(1):63-72. PubMed ID: 2157397
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function.
    Sambhara S; Kurichh A; Miranda R; Tumpey T; Rowe T; Renshaw M; Arpino R; Tamane A; Kandil A; James O; Underdown B; Klein M; Katz J; Burt D
    Cell Immunol; 2001 Aug; 211(2):143-53. PubMed ID: 11591118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dynamical model of human immune response to influenza A virus infection.
    Hancioglu B; Swigon D; Clermont G
    J Theor Biol; 2007 May; 246(1):70-86. PubMed ID: 17266989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maternal antibody and its effect on infectious bursal disease immunization.
    Naqi SA; Marquez B; Sahin N
    Avian Dis; 1983; 27(3):623-31. PubMed ID: 6314972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immune profile of infectious bursal disease: I. Effect of infectious bursal disease virus on peripheral blood T and B lymphocytes of chickens.
    Sivanandan V; Maheswaran SK
    Avian Dis; 1980; 24(3):715-25. PubMed ID: 6255926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine.
    Sharma JM
    Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viral carrier status is instilled by viral regulatory particles.
    Wheatland R
    Med Hypotheses; 2010 Apr; 74(4):688-91. PubMed ID: 19948378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of T cell immunosuppression by infectious bursal disease virus of chickens.
    Sharma JM; Fredericksen TL
    Prog Clin Biol Res; 1987; 238():283-94. PubMed ID: 3037563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis of viral infections. Basic concepts derived from the reovirus model.
    Sharpe AH; Fields BN
    N Engl J Med; 1985 Feb; 312(8):486-97. PubMed ID: 2982096
    [No Abstract]   [Full Text] [Related]  

  • 37. Reproducibility and usability of chronic virus infection model using agent-based simulation; comparing with a mathematical model.
    Itakura J; Kurosaki M; Itakura Y; Maekawa S; Asahina Y; Izumi N; Enomoto N
    Biosystems; 2010 Jan; 99(1):70-8. PubMed ID: 19751799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral host resistance studies.
    Freebern WJ
    Methods Mol Biol; 2010; 598():109-17. PubMed ID: 19967509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of viral glycoproteins for infectivity and pathogenicity.
    Rott R; Klenk HD
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Aug; 266(1-2):145-54. PubMed ID: 3122462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological aspects of the prevention of viral diseases. WHO Workshop.
    WHO Workshop
    Bull World Health Organ; 1987; 65(1):1-10. PubMed ID: 3495361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.